| NCT ID | NCT04640584 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Otto Bock Healthcare Products GmbH |
| Condition | Pareses |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2015-04 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2015-04 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To gather prospective safety and effectiveness data for the C-Brace System following the standard of care.
Eligibility Criteria
Inclusion Criteria: * Patient has been evaluated and successfully tested with the Trial Tool, and has been casted for a C-Brace. * Patient is able to communicate, provide feedback, understand and follow instructions during the course of the registry. * Patient is willing to provide informed consent. Exclusion Criteria: * Patient is geographically inaccessible to comply and participate in the registry. * Patient has not been casted for a C-Brace fitting.
Contact & Investigator
Frank Braatz, Prof.
PRINCIPAL INVESTIGATOR
Private University of Applied Sciences
Frequently Asked Questions
Who can join the NCT04640584 clinical trial?
This trial is open to participants of all sexes, studying Pareses. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04640584 currently recruiting?
Yes, NCT04640584 is actively recruiting participants. Contact the research team at russ.lundstrom@ottobock.com for enrollment information.
Where is the NCT04640584 trial being conducted?
This trial is being conducted at Harrison, United States, Rogers, United States, San Diego, United States, San Diego, United States and 11 additional locations.
Who is sponsoring the NCT04640584 clinical trial?
NCT04640584 is sponsored by Otto Bock Healthcare Products GmbH. The principal investigator is Frank Braatz, Prof. at Private University of Applied Sciences. The trial plans to enroll 250 participants.